Spotlight on Sam Somech
What made you decide to join SuperDerivatives after your history of running your own concerns?
From the beginning of SuperDerivatives as a company, I was an initial investor and sat on the board of directors. I've never invested in start-up companies before, but SuperDerivatives was an exception. I saw that over their first year they met their goals and provided accurate forecasts of their position and number of new customers. So I invested in SuperDerivatives, I joined the board of directors
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact [email protected] to find out more.
You are currently unable to copy this content. Please contact [email protected] to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
More on Operations
Waters Wavelength
Waters Wavelength Podcast: Episode 226 (M&A and people)
On this episode of the Wavelength Podcast, Wei-Shen and Tony talk about the importance of communication when it comes to M&A activity within a company.
Subscribe to Weekly Wrap emails
Most read
- The curious case of Larry Fondren and DelphX
- Bloomberg RHub fee hike reflects cost pressures of regulatory reporting industry
- Itiviti’s Blueprint for Success—Investing in People and Products
- Esma: Both OTC identifiers will not be required in Emir reporting
- All roads lead to Bergamo: Euronext eyes new home for its tech